Xuantai Pharmaceuticals: Qiuhe Entrepreneurship has reduced its holdings by 0.7098%

Announcement from Xuantai Pharmaceuticals: Shareholder Nanjing Qihuo Entrepreneurship Investment Partnership originally held 25.798 million shares, accounting for 5.6907%. Its reduction plan was implemented from August 5, 2025 to November 4, during which 3.218 million shares were reduced through centralized bidding, a reduction ratio of 0.7098%, with a reduction price range of 10.5 to 13.13 yuan/share, realizing 37.4141 million yuan in cash. Currently holding 22.58 million shares, accounting for 4.9808%, the reduction plan has expired and been completed.